Combination products are still relatively new delivery systems for the healthcare market. New approaches are crucial for precise administration without inducing any harm. New laws and regulations have led to the increase in technological requirements within this industry. The drug/device combination products summit provides the appropriate platform for industry leaders to discuss the best practices in Drug/Device Combination Products development.
Clariant is one of the sponsors of this year’s edition and will also showcase its dedicated Mevopur® portfolio of color and additive solutions, available as compounds or masterbatches, for drug delivery devices in the exhibition area.